Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Gilead Sciences Inc

GILD
65,27
1,71 (2,69%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202409:00BWNew Kite Clinical Research and Real-World Evidence for..
12/6/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202410:30BWGilead Announces New England Journal of Medicine Publication..
05/6/202408:00BWGilead’s Seladelpar Demonstrated a Sustained and Consistent..
03/6/202416:00BWKite’s Tecartus® Demonstrates Sustained Overall Survival in..
03/6/202415:00BWEncouraging New Data Presented on Kite’s Yescarta® for..
02/6/202414:00BWGilead and Arcus Announce Etrumadenant Plus Zimberelimab..
01/6/202414:00BWGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus..
31/5/202414:07BWEVOKE-01 Study Results in Metastatic NSCLC to Be Presented..
30/5/202422:45BWGilead Provides Update on Phase 3 TROPiCS-04 Study
22/5/202414:30BWGilead to Present Latest Research Across Key Liver Disease..
18/5/202414:30BWInvestigational Seladelpar Demonstrates Significant..
14/5/202416:09BWKite Data at EHA 2024 Demonstrate Positive Patient Outcomes..
09/5/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:11EDGAR2Form 8-K - Current report
09/5/202422:05BWKite and Arcellx Continue Momentum with Advances in..
09/5/202421:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202421:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:58EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:30BWGilead and Kite Oncology to Highlight Broad and Diverse..
30/4/202422:05BWGilead Sciences to Present at Upcoming Investor Conferences
26/4/202414:00BWFDA Approves Biktarvy® Label Update With Data for Pregnant..
26/4/202413:47IHMARKETNEWSExxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian..
25/4/202422:02BWGilead Sciences Announces First Quarter 2024 Financial..
25/4/202413:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
08/4/202422:05BWGilead Sciences to Release First Quarter 2024 Financial..
28/3/202413:30BWFDA Expands Indication for Gilead's Vemlidy (Tenofovir..
28/3/202412:00GLOBEGilead and Xilio Announce Exclusive License Agreement for..
22/3/202414:18BWGilead Sciences Announces Completion of Acquisition of..
19/3/202400:29BWCenter for Disease Analysis Foundation Announces First Round..
11/3/202413:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/3/202413:24BWGilead Sciences Announces Expiration of Hart-Scott-Rodino..
06/3/202422:30BWBiktarvy® Demonstrates High Rates of Viral Suppression in..
06/3/202416:25BWGilead and Merck Announce Phase 2 Data Showing an..
06/3/202414:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/3/202422:35BWNew Real-World Data Further Support the Use of Veklury®..
05/3/202422:30BWGilead’s Innovative HIV Treatment Research Pipeline Aims to..
01/3/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:49EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:38EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 62,75 Min: 62,71 Max: 65,62
Chiusura: 63,56

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network